Research Update: MED ParentCo L.P. Proposed First-Lien Debt Rated 'B-'; Ratings Affirmed On Refinanced Capital Structure; Outlook Stable - S&P Global Ratings’ Credit Research

Research Update: MED ParentCo L.P. Proposed First-Lien Debt Rated 'B-'; Ratings Affirmed On Refinanced Capital Structure; Outlook Stable

Research Update: MED ParentCo L.P. Proposed First-Lien Debt Rated 'B-'; Ratings Affirmed On Refinanced Capital Structure; Outlook Stable - S&P Global Ratings’ Credit Research
Research Update: MED ParentCo L.P. Proposed First-Lien Debt Rated 'B-'; Ratings Affirmed On Refinanced Capital Structure; Outlook Stable
Published Mar 26, 2024
7 pages (2763 words) — Published Mar 26, 2024
Price US$ 225.00  |  Buy this Report Now

About This Report

  
Abstract:

MED ParentCo L.P. plans to issue a new $1.4 billion first-lien term loan maturing in April 2031 and $425 million of payment in kind (PIK) preferred equity to refinance its existing first- and second-lien term loans. The company will also upsize its revolver to $150 million and extend the maturity to April 2029. We have affirmed our 'B-' issuer credit rating with a stable outlook. At the same time, we assigned our 'B-' issue-level rating and '3' recovery rating to the proposed first-lien debt. The '3' recovery rating indicates our expectation of meaningful (50%-70%; rounded estimate: 55%) recovery in the event of a payment default. The stable outlook on MED reflects our view that its credit metrics and operating margins

  
Brief Excerpt:

...- MED ParentCo L.P. plans to issue a new $1.4 billion first-lien term loan maturing in April 2031 and $425 million of payment in kind (PIK) preferred equity to refinance its existing first- and second-lien term loans. - The company will also upsize its revolver to $150 million and extend the maturity to April 2029. - We have affirmed our 'B-' issuer credit rating with a stable outlook. - At the same time, we assigned our 'B-' issue-level rating and '3' recovery rating to the proposed first-lien debt. The '3' recovery rating indicates our expectation of meaningful (50%-70%; rounded estimate: 55%) recovery in the event of a payment default. - The stable outlook on MED reflects our view that its credit metrics and operating margins will continue to improve over the next 12 months due to integration of past acquisitions and improved EBITDA generation....

  
Report Type:

Research Update

Ticker
1733885D
Issuer
Sector
Global Issuers
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Research Update: MED ParentCo L.P. Proposed First-Lien Debt Rated 'B-'; Ratings Affirmed On Refinanced Capital Structure; Outlook Stable" Mar 26, 2024. Alacra Store. May 06, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-MED-ParentCo-L-P-Proposed-First-Lien-Debt-Rated-B-Ratings-Affirmed-On-Refinanced-Capital-Structure-Outlook-Stable-3213242>
  
APA:
S&P Global Ratings’ Credit Research. (). Research Update: MED ParentCo L.P. Proposed First-Lien Debt Rated 'B-'; Ratings Affirmed On Refinanced Capital Structure; Outlook Stable Mar 26, 2024. New York, NY: Alacra Store. Retrieved May 06, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-MED-ParentCo-L-P-Proposed-First-Lien-Debt-Rated-B-Ratings-Affirmed-On-Refinanced-Capital-Structure-Outlook-Stable-3213242>
  
US$ 225.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.